Snipe Medical — Biomedical Watch V2

Traitements2programmes

Essais1liés

Publications0liées

SourceDBlocale

Traitements

2

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
EAS1 SystemA Prospective, open label, multi center, single arm, First in Human study to assess the safety and initial performance of EAS1 system for Irreversible Electroporation (IRE) ablation of lung cancer in subjects eligible for tumor resection	Cancer	Non applicable	À vérifier	Israel, Spain, United Kingdom	À vérifier
EAS1 SystemA Prospective, open label, multi center, single arm, First in Human study to assess the safety and initial performance of EAS1 system for Irreversible Electroporation (IRE) ablation of lung cancer in subjects eligible for tumor resection	Cancer	Non applicable	À vérifier	Israel, Spain, United Kingdom	À vérifier

Essais cliniques

1

Molécule	Indication / population	Phase	NCT	Titre	Statut
EAS1 System	Cancer	Non applicable	NCT06423690	First in Human Study for the Assessment of Safety and Initial Performance of the EAS1 System	RECRUITING

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.